课题基金 / 基金详情

Identifying the role of 4-1BB in generation and persistence of VACV-CD8 memory

Identifying the role of 4-1BB in generation and persistence of VACV-CD8 memory
确定 4-1BB 在 VACV-CD8 内存的生成和持久化中的作用
批准号:
8003944
负责人:
Yuan Zhao
金额:
$5.05万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2013-06-30

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
描述(由申请方提供):牛痘病毒(VACV)提供针对天花病毒(天花病原体)的持久保护。VACV特异性CD 8记忆T细胞有助于保护,但其分子控制尚未完全了解。本项目的目标是确定和了解TNF受体家族成员4-1BB在控制内源性VACV特异性记忆CD 8 T细胞的产生和持久性中的作用,并研究靶向该分子是否可以增强肽或减毒病毒免疫的效力,以防止随后的感染。VACV被用作针对广泛的传染性病原体的疫苗接种的载体,并且从我们的研究中获得的知识将有望帮助开发安全但有效的包含VACV载体的疫苗。含有卵清蛋白(OVA)的确定CD 8 T细胞表位的野生型、减毒和重组牛痘病毒将用于缺乏4-1BB或4-1BBL的敲除动物的实验中,以显示其在产生VACV特异性CD 8 T细胞中的贡献。此外,与VACV-OVA反应且缺乏4-1BB的TCR转基因CD 8 T细胞将用于通过在体内追踪过继转移的T细胞来特异性地限定4-1BB对T细胞的作用。4-1BB的激动剂试剂,单独或与各种其他佐剂组合,将在引发可以中和致死性感染的保护性T细胞群方面进行研究。这项研究应该提供关于4-1BB在控制T细胞对VACV应答中的重要性的宝贵数据,并强调其作为未来疫苗接种策略靶点的潜在作用。 公共卫生相关性:牛痘病毒(VACV)提供持久的保护,防止天花病毒,天花的代理人。这项研究旨在了解有助于保护的病毒特异性CD 8记忆T细胞的分子控制。本研究将有助于开发更好的VACV疫苗用于感染性疾病以及癌症免疫治疗。
英文摘要
DESCRIPTION (provided by applicant): Vaccinia virus (VACV) affords long-lasting protection against variola virus, the agent of smallpox. VACV- specific CD8 memory T cells contribute to protection but their molecular control is not fully understood. The goal of the current project is to identify and understand the role of 4-1BB, a member of the TNF receptor family, in controlling the generation and persistence of endogenous VACV-specific memory CD8 T cells, and to investigate whether targeting this molecule can enhance the efficacy of peptide or attenuated virus immunization to protect against subsequent infection. VACV is being used as a vector for vaccination against a wide range of infectious pathogens and knowledge gained from our studies will hopefully aid the development of safe but effective vaccines comprising VACV vectors. Wild type, attenuated, and recombinant vaccinia virus, containing a defined CD8 T cell epitope of ovalbumin (OVA), will be used in experiments with knockout animals lacking 4-1BB or 4-1BBL to show their contribution in generating VACV-specific CD8 T cells. Additionally, TCR transgenic CD8 T cells, reactive with VACV-OVA, and deficient in 4-1BB, will be used to specifically define the role of 4-1BB on a T cell by tracking adoptively transferred T cells in vivo. Agonist reagents to 4-1BB, alone or in combination with various other adjuvants, will be studied in terms of eliciting protective T cell populations that can neutralize lethal infections. This research should provide invaluable data on the importance of 4-1BB in controlling T cell responses to VACV and highlight its potential role as a target for future vaccination strategies. PUBLIC HEALTH RELEVANCE: Vaccinia virus (VACV) affords long-lasting protection against variola virus, the agent of smallpox. This research aims to understand the molecular control of virus-specific CD8 memory T cells that contribute to protection. This study will benefit the development of better VACV vaccines for infectious diseases as well as cancer immunotherapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    乔安娜
  • 依托单位: